The Targeted Radiopharmaceuticals (TRP) Target Selection and Drug Design Summit explores the development and design of targeted radiopharmaceuticals, focusing on selecting optimal targets, rational drug design, and advancing therapeutic strategies to address unmet medical needs.
Key Topics
- Understanding Unique Characteristics of an Optimal Radiopharmaceutical Target to Guide Ideal Selection
- Mining New Radiopharmaceutical Targets for Novel Therapeutics to Differentiate Your Pipeline
- Selecting Characterized & Novel Targets for Use with Radiopharmaceutical Candidates to Address Unmet Medical Need
- Rational Drug Design for Radiopharmaceuticals: Cutting-Edge Targeting Moieties for Optimal Drug Properties
- Understanding Radiobiological Mechanisms of Killing & Immune Stimulation to Match Optimal Radiopharmaceutical Targets
- Rational Drug Design for Radiopharmaceuticals – Targeting Strategies
- Rational Drug Design for Radiopharmaceuticals – Chelator & Linker Developments
- Exploring Radiation Absorption, Early Preclinical Dosimetry & Novel Assay Development
